The authors examined 3 hypotheses: internalized stigma would be a stronger predictor of barriers to seeking mental health care than perceived stigma, alienation would be a stronger predictor of barriers than other components, and depression severity would modify the relationship of depression stigma and barriers to care.
Researchers used patient databases to investigate the association between obesity treatment interventions with a dietary component and the change in symptoms of depression and anxiety in pediatric patients who were overweight or obese.
Higher rates of hopelessness, loneliness, anhedonia, social anxiety, and younger age were highly correlated with suicidal ideation in patients with major depressive disorder, based on a review of qualitative data.
Patients with schizophrenia or a mood disorder who switched antipsychotic treatment had an increased likelihood for relapse, healthcare resource utilization, and extrapyramidal symptoms.
For patients with major depressive disorder, neither second-generation antidepressants nor cognitive behavioral therapy offers consistently superior cost-effectiveness.
Off-label use of oxcarbazepine and amantadine HCl appeared effective in maintaining improved symptomology in adolescent female patients with borderline personality disorder.
For both patients with ulcerative colitis and those with Crohn disease, psychiatric diagnoses were more common in those who were elderly (greater than 65 years old), women, and white, and those with psychiatric conditions more frequently had a history of alcohol abuse, tobacco and substance abuse, personality disorder, and corticosteroid use.
A recent report published in the journal Neuropsychobiology describes the case of a 34-year-old woman with major depressive disorder whose symptoms improved following the initiation of an elimination diet.
